CA
GH icon

CoreCap Advisors’s Guardant Health GH Stock Holding History

CoreCap Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.15K Hold
61
– – ﹤0.01% 2095
2026
Q1 		$5.63K Hold
61
– – ﹤0.01% 2149
2025
Q4 		$6.23K Hold
61
– – ﹤0.01% 2119
2025
Q3 		$3.81K Hold
61
– – ﹤0.01% 2235
2025
Q2 		$3.17K Hold
61
– – ﹤0.01% 2229
2025
Q1 		$2.6K Buy
61
+1
+2% +$43 ﹤0.01% 2284
2024
Q4 		$1.83K Buy
60
+50
+500% +$1.41K ﹤0.01% 2250
2024
Q3 		$229 Hold
10
– – ﹤0.01% 2486
2024
Q2 		$289 Buy
10
+3
+43% +$70 ﹤0.01% 1490
2024
Q1 		$144 Buy
+7
New +$150 ﹤0.01% 2426
2022
Q4 		$381 Buy
+14
New +$641 ﹤0.01% 2204
2022
Q3 		– Sell
-14
Closed -$1K – 1123
2022
Q2 		$1K Buy
+14
New +$694 ﹤0.01% 1987

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CoreCap Advisors's GH Position: Q2 2026 in Review

CoreCap Advisors held its Guardant Health (GH) position steady in Q2 2026 at 61 shares worth $9.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

CoreCap Advisors first reported a position in GH in Q2 2022 and has held it in 12 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • CoreCap Advisors held 61 shares of Guardant Health worth $9.15K as of Q2 2026.
  • CoreCap Advisors left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2095 holding.
  • CoreCap Advisors first reported a position in Guardant Health in Q2 2022 and has held it in 12 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.